Scholar Rock

Senior Manager / Associate Director, HCP Marketing (US)

Scholar Rock  •  Cambridge, MA (Onsite)  •  22 hours ago
Apply
Save Job
Mark Applied Mark Interviewed Mark Offered
Hide Job Report Job
AI can make mistakes so check important info. Chat history is never stored.

Job Description

Scholar Rock is a late-stage global biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. As a global leader in myostatin biology, a field focused on proteins that regulate muscle mass, the Company is named for the visual resemblance of a scholar rock to protein structures. Our commitment to unlock fundamentally different treatment approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. Scholar Rock works every day to create new possibilities for patients through its highly innovative anti-myostatin program, including opportunities in additional rare neuromuscular diseases. Learn more at ScholarRock.com and follow @ScholarRock on X and on LinkedIn
 
of Position:

The Senior Manager / Associate Director, HCP Marketing (US) will play a key role in the execution of Scholar Rock’s first U.S. commercial launch. This role will work with the HCP Marketing team lead to execute the HCP marketing strategy and ensure tactical pull-through for apitegromab, the first and only muscle-targeted therapy for spinal muscular atrophy (SMA).

This individual will support the U.S. HCP brand strategy through commercialization, ensuring clear differentiation, compelling scientific communication, and flawless execution across channels. The role will work closely cross-functional partners deliver an integrated experience for HCPs and ensure brand continuity across tactics.

This is a high-impact, high-visibility role within a fast-growing organization and an opportunity to contribute to the commercial foundation of Scholar Rock’s first marketed product.
 
 
 

Position Responsibilities

U.S. HCP Execution

  • Support execution of the U.S. HCP brand strategy for apitegromab, grounded in deep understanding of the SMA landscape, unmet need, and clinical data.
  • Translate strategy into high-quality, compliant HCP promotional tactics across personal and non-personal channels.
  • Partner with field-based team members to ensure strong integration between HCP marketing and field execution.
  • Collaborate with agency partners and vendors to deliver best-in-class creative and execution.

Cross-Functional Leadership

  • Serve as a connector across the U.S. Commercial Team, collaborating with Medical Affairs, Market Access, Patient Services, Regulatory, Legal, and Compliance.
  • Build strong relationships with cross-functional partners in order to ensure brand continuity across all HCP-facing materials and tactics.

Candidate Qualifications

  • Bachelor’s degree required; advanced degree preferred.
  • 3+ years of experience in pharmaceutical or biotechnology marketing, with experience in U.S. HCP marketing or Medical Education preferred
  • MLR (or equivalent) experience strongly preferred.
  • Understanding and experience navigating compliant HCP messaging.
  • Strong strategic mindset with hands-on execution capability.
  • Experience working in matrixed, cross-functional teams in a fast-paced environment.
  • Excellent communication, influence, and stakeholder-management skills.
  • Experience in neurology, neuromuscular disease, or rare disease preferred.
  • Willingness to travel as needed (anticipated up to ~30%).
Scholar Rock is an Equal Opportunity Employer. We celebrate diversity and are committed to creating an inclusive environment for all employees 
Scholar Rock

About Scholar Rock

Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role.

Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at ScholarRock.com and follow @ScholarRock on X.

For additional information on our guidelines, please visit https://scholarrock.com/community-guidelines/

For more information on how Scholar Rock collects, uses, and shares personal information, please visit: https://scholarrock.com/privacy-policy/

Industry
Unknown
Company Size
201-500 employees
Headquarters
Cambridge, Massachusetts
Year Founded
2012
Website
scholarrock.com
Social Media